Abstract
Endoscopic papillotomy, introduced in 1973, is now an established endoscopic procedure for treatment of various diseases of the papilla, bile duct, and pancreas. This article describes the use of this technique, the various instruments that can be employed, the instances in which it is indicated, and its associated complications and risks. Alternative treatments are also summarized.
Similar content being viewed by others
References and Recommended Reading
Classen M, Demling LL: Endoskopische Sphinkterotomie der Papilla Vateri und Steinextraktion aus dem Ductus choledochus. Dtsch Med Wschr 1974, 99:496–497.
Kawai K, Akasaka Y, Murakami K, et al.: Endoscopic sphincterotomy of the ampulla of Vater. Gastrointest Endosc 1974, 20:148–151.
Wright BE, Cass OW, Freeman ML: ERCP in patients with longlimb Roux-en-Y gastrojejunostomy and intact papilla. Gastrointest Endosc 2002, 56:225–232.
Kim MH, Lee SK, Lee MH, et al.: Endoscopic retrograde cholangiopancreatography and needle-knife sphincterotomy in patients with Billroth II gastrectomy: a comparative study of the forward-viewing endoscope and the side-viewing duodenoscope. Endoscopy 1997, 29:82–85.
Costamagna G, Mutignani M, Gabrielli A, et al.: Diagnostic and therapeutic ERCP in patients with Billroth II gastrectomy. Acta Gastroenterol Belg 1994, 57:155–162.
Born P, Sandschin W, Rösch T: Percutaneous antegrade sphincterotomy under endoscopic retrograde control: report of two cases. Endoscopy 2002, 34:512–513.
Mönckemüller KE, Linder JD, Fry LC: Modified rendezvous technique for biliary cannulation [abstract]. Endoscopy 2002, 34:936.
Burmeister E, Niehaus J, Leineweber T, Huetteroth T: EUS-cholangio-drainage of the bile duct: report of 4 cases. Gastrointest Endosc 2003, 57:246–251.
Battaille L, Deprez P: A new application for therapeutic EUS: main pancreatic duct drainage with a ‘pancreatic rendezvous technique’. Gastrointest Endosc 2002, 55:740–743.
Sriram PVJ, Rao GV, Nageshwar Reddy D: The precut—when, where and how? A review. Endoscopy 2003, 35 (Suppl 1): S24-S30.
Kin H, Mochizuki T, Matsumura K, et al.: Needle-knife papillotomy with pancreatic stent: a prospective evaluation of efficacy and complications [abstract]. Gastrointest Endosc 2003, 57:AB192.
Park JJ, Kim SS, Kim YK, et al.: Biliary drainage by endoscopic choledochoduodenal fistulotomy in patients with papillary carcinoma. Gastrointest Endosc 2002, 55:730–735.
Fazel A, Quadri A, Catalano MF, et al.: Does a pancreatic duct stent prevent post-ERCP pancreatitis? A prospective randomized study. Gastrointest Endosc 2003, 57:291–294. This study deals with the important concern over post-ERCP and post-EPT pancreatitis and how to avoid it. In patients who bear a high risk of pancreatitis after this procedure, the authors were able to discern who would benefit from prophylactic insertion of a small-caliber stent into the pancreatic duct.
Shah RJ, Antillon MR, Springer EW, et al.: A new rotatable papillotome (RP) in complex therapeutic ERCP: indications for use and results [abstract]. Gastrointest Endosc 2003, 57:AB206.
Freeman ML, Nelson DB, Sherman S, et al.: Complications of endoscopic biliary sphincterotomy. N Engl J Med 1996, 335:909–918. The most important prospective study on the complications of endoscopic sphincterotomy. Complication rates are documented, and special risk factors, such as SOD, are identified. The authors initiated further efforts to reduce these risks, such as prophylactic stenting of the pancreatic duct.
Oviedo JA, Barrison A, Lichtenstein DR: Endoscopic argon plasma coagulation for refractory postsphincterotomy bleeding: report of two cases. Gastrointest Endosc 2003, 58:148–151.
Guidelines of the European Society of Gastrointestinal Endoscopy (ESGE): Antibiotic prophylaxis for gastrointestinal endoscopy. Endoscopy 1998, 30:318–324
Sherman S, Blaut U, Watkins JL, et al.: Does prophylactic administration of corticosteroid reduce the risk and severity of post-ERCP pancreatitis: a randomized, prospective, multicenter study. Gastrointest Endosc 2003, 58:23–29.
Manolakopoulos S, Avgerinos A, Vlachogiannakos J, et al.: Octreotide versus hydrocortisone versus placebo in the prevention of post-ERCP pancreatitis: a multicenter randomized controlled trial. Gastrointest Endosc 2002, 55:470–475.
Andriulli A, Clemente R, Solmi L, et al.: Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: a multicenter, placebo-controlled, randomized clinical trial. Gastrointest Endosc 2002, 56:488–495.
Prat F, Amaris J, Ducot B, et al.: Nifedipine for prevention of post-ERCP pancreatitis: a prospective, double-blind randomized study. Gastrointest Endosc 2002, 56:202–208.
Rabenstein T, Roggenbruck S, Framke B, et al.: Complications of endoscopic sphincterotomy: Can heparin prevent acute pancreatitis after ERCP? Gastrointest Endosc 2002, 55:476–483.
Rabenstein T, Fischer B, Wiesner V, et al.: Low-molecularweight heparin does not prevent acute post-ERCP pancreatitis [abstract]. Gastrointest Endosc 2003, 57:AB189.
Murray B, Carter R, Imrie C, et al.: Diclofenac reduces the incidence of acute pancreatitis after endoscopic retrograde cholangiopancreatography. Gastroenterology 2003, 124:1786–1791.
Akashi R, Kiyozumi T, Tanaka T, et al.: Mechanism of pancreatitis caused by ERCP. Gastrointest Endosc 2002, 55:50–54. This study describes another approach to the problem of pancreatitis after EPT/sphincterotomy. The authors show that obstruction of the pancreatic outflow is an important pathogenetic factor and therefore supports data from other studies documenting a reduction of pancreatitis by prophylactic stent insertion into the pancreatic duct.
Tarnasky P, Cunningham J, Cotton P, et al.: Pancreatic sphincter hypertension increases the risk of post-ERCP pancreatitis. Endoscopy 1997, 29:252–257.
Smithline A, Silverman W, Rogers D, et al.: Effect of prophylactic main pancreatic duct stenting on the incidence of biliary endoscopic sphincterotomy-induced pancreatitis in high-risk patients. Gastrointest Endosc 1993, 39:652–657.
Sherman S, Earle D, Bucksot L, et al.: Does leaving a main pancreatic duct stent in place reduce the incidence of precut biliary sphincterotomy (ES)-induced pancreatitis ? A final analysis of a prospective study [abstract]. Gastrointest Endosc 1996, 43:413A.
Singh P, Sivak MV, Agarwal D, et al.: Prophylactic pancreatic stenting for prevention of post-ERCP acute pancreatitis: a meta-analysis of controlled studies [abstract]. Gastointest Endosc 2003, 57:AB89.
Stefanidis G, Karamanolis G, Viazis N, et al.: A comparative study of postendoscopic sphincterotomy complications with various types of electrosurgical current in patients with choledocholithiasis. Gastrointest Endosc 2003, 57:192–197.
Mcintosh D, Love J, Abraham N: Endoscopic sphincterotomy using pure-cut current does not reduce the risk of post-ERCP pancreatitis: a prospective randomized trial [abstract]. Gastrointest Endosc 2003, 57:AB189.
Costamagna G, Tringali A, Shah SK, et al.: Long-term follow-up of patients after endoscopic sphincterotomy for choledocholithiasis, and risk factors for recurrence. Endoscopy 2002, 34:273–279.
Neuhaus H: Endoscopic and percutaneous treatment of difficult bile duct stones. Endoscopy 2003, 35(Suppl 1): S31-S34.
Mora J, Aguilera V, Sala T, et al.: Endoscopic treatment combined with extracorporeal shock wave lithotripsy of difficult bile duct stones. Gastroenterol Hepatol 2002, 25:585–588.
Minami A, Fujita R: A new technique for removal of bile duct stones with an expandable metallic stent. Gastrointest Endosc 2003, 57:945–948.
Buscarini E, Tansini P, Vallisa D, et al.: EUS for suspected choledocholithiasis: Do benefits outweigh costs ? A prospective, controlled study. Gastrointest Endosc 2003, 57:510–518.
Sivak MV: EUS for bile duct stones: How does it compare with ERCP? Gastrointest Endosc 2003, 56(Suppl):S175-S177.
Fulcher AS: MRCP and ERCP in the diagnosis of common bile duct stones. Gastrointest Endosc 2002, 56(Suppl):S178-S182.
Lee DWH, Chan ACW, Lam Y, et al.: Biliary decompression by nasobiliary catheter or biliary stent in acute suppurative cholangitis: a prospective randomized trial. Gastrointest Endosc 2002, 56:361–365.
van Lent AUG, Bartelsman JFWM, Tytgat GNJ, et al.: Duration of antibiotic therapy for cholangitis after successful endoscopic drainage of the biliary tract. Gastrointest Endosc 2002, 55:518–522.
Mark DH, Lefevre F, Flamm CR, Aronson N: Evidence-based assessment of ERCP in the treatment of pancreatitis. Gastrointest Endosc 2002, 56(Suppl):S249-S254.
Kozarek R: Role of ERCP in acute pancreatitis. Gastrointest Endosc 2002, 56(Suppl):S231-S236.
Telford JJ, Farrell JJ, Saltzman JR, et al.: Pancreatic stent placement for duct disruption. Gastrointest Endosc 2002, 56:18–24. Pancreatic disruption and its various clinical consequences are described. Furthermore, the beneficial effect of stent insertion in the pancreatic duct is clearly demonstrated. These data confirm the results of earlier studies and are a strong stimulus for a more "aggressive" approach. The potential benefits for patients seem to outweigh the risks by far.
Kaw M, Al Antably Y, Kaw P: Management of gallstone pancreatitis: cholecystectomy or ERCP and endoscopic sphincterotomy. Gastrointest Endosc 2002, 56:61–65.
Park SH, Watkins JL, Fogel EL, et al.: Long-term outcome of endoscopic dual pancreatobiliry sphincterotomy in patients with manometry-documented sphincter of Oddi dysfunction and normal pancreatogram. Gastrointest Endosc 2003, 57:483–491.
Abraham NS, Barkun JS, Barkun AN: Palliation of malignant biliary obstruction: a prospective trial examining impact on quality of life. Gastrointest Endosc 2002, 56:835–841.
Cheng JLS, Bruno MJ, Bergmann JJ, et al.: Endoscopic palliation of patients with biliary obstruction caused by nonresectable hilar cholangiocarcinoma: efficacy of self-expandable metallic Wallstents. Gastrointest Endosc 2002, 56:33–39.
De Palma GD, Pezzullo A, Rega M, et al.: Unilateral placement of metallic stents for malignant hilar obstruction: a prospective study. Gastrointest Endosc 2003, 58:50–53.
Kaassis M, Boyer J, Dumas R, et al.: Plastic or metal stents for malignant stricture of the common bile duct? Results of a randomized prospective study. Gastrointest Endosc 2003, 57:178–182.
Schilling D, Rink G, Arnold JC, et al.: Prospective, randomized, single-center trial comparing 3 different 10F plastic stents in malignant mid and distal bile duct strictures. Gastrointest Endosc 2003, 58:54–58.
Catalano MF, Geenen JE, Lehman GA, et al.: "Tannenbaum" Teflon stents versus traditional polyethylene stents for treatment ofmalignant biliary stricture. Gastrointest Endosc 2002, 55:354–358.
Saleh MMA, Norregaard P, Jorgensen HL, et al.: Preoperative endoscopic stent placement before pancreaticoduodenectomy: a meta-analysis of the effect on morbidity and mortality. Gastrointest Endosc 2002, 56:529–534.
Varadarajulu S, Noone T, Hawes RH, Cotton PB: Pancreatic duct stent insertion for functional smoldering pancreatitis. Gastrointest Endosc 2003, 58:438–441.
Lehman GA: Role of ERCP and other endoscopic modalities in chronic pancreatitis. Gastrointest Endosc 2002 56(Suppl):S237-S240.
Holm M, Matzen P: Stenting and extracorporeal shock wave lithotripsy in chronic pancreatitis. Scand J Gastroenterol 2003, 38:328–331.
Keeling SP, Freeman ML: Placement of self-expanding metallic stents in the pancreatic duct for treatment of obstructive complications of pancreatic cancer. Gastrointest Endosc 2003, 57:756–759.
Eickhoff A, Jakobs R, Leonhardt A, et al.: Self-expandable metal mesh stents for common bile duct stenosis in chronic pancreatitis: retrospective evaluation of long-term follow-up and clinical outcome of a pilot study. Z Gastroenterol 2003, 41:649–654.
Van Berkel A-M, Van Westerloo D, Cahen D, et al.: Efficacy of Wallstents in benign biliary strictures due to chronic pancreatitis [abstract]. Gastrointest Endosc 2003, 57:AB198.
Brodsky JA, Marks JM, Malm JA, et al.: Sphincter of Oddi injection with botulinum toxin is as effective as endobiliary stent in resolving cystic duct leaks in a canine model. Gastrointest Endosc 2002, 56:849–851.
Moreto M, Zaballa M, Casado I, et al.: Transdermal glyceryl trinitrate for prevention of post-ERCP pancreatitis: a randomized double-blind trial. Gastrointest Endosc 2003, 57:1–7.
Bergmann JJ, Rauws EA, Fockens P, et al.: Randomized trial of endoscopic balloon dilatation versus endoscopic sphincterotomy for removal of bile duct stones. Lancet 1997, 349:1124–1129.
Fujita N, Maguchi H, Komatsu Y, et al., for the JESED Study Group: Endoscopic sphincterotomy and endoscopic papillary balloon dilatation for bile duct stones: a prospective randomized controlled multicenter trial. Gastrointest Endosc 2003, 57:151–155.
Ersoz G, Tekesin O, Ozutemiz AO, Gunsar F: Biliary sphincterotomy plus dilation with a large balloon for bile duct stones that are difficult to extract. Gastrointest Endosc 2003, 57:156–159.
Sugiyama M, Izumisato Y, Abe N, et al.: Predictive factors for acute pancreatitis and hyperamylasemia after endoscopic papillary balloon dilatation. Gastrointest Endosc 2003, 57:531–535.
Ueno N, Ozawa Y, Aizawa T: Prognostic factors for recurrence of bile duct stones after endoscopic treatment by sphincter dilation. Gastrointest Endosc 2003, 58:336–340.
DiSario JA: Endoscopic balloon dilatation for extraction of bile duct stones: the devil is in the details. Gastrointest Endosc 2003, 57:282–285.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Classen, M., Born, P. Endoscopic papillotomy, syn. sphincterotomy: Results from the past two years. Curr Gastroenterol Rep 6, 169–175 (2004). https://doi.org/10.1007/s11894-004-0045-y
Issue Date:
DOI: https://doi.org/10.1007/s11894-004-0045-y